Research areas

Reig Jofre’s R&D team is composed of 47 technicians with ample experience in the following areas of research:

  • Bioequivalence studies.
  • Clinical pharmacokinetics and bioavailability studies.
  • Drug interaction studies.
  • Preclinical pharmacokinetics.
  • Preclinical toxicokinetics.
  • Analysis and identification of metabolites.

Based on this experience, and with a specialized emphasis on the therapeutic areas of dermatology, gynecology and respiration, the R&D team focuses its activity on:

  • Development of new pharmaceutical products or variations on known active ingredients in order to modify their release, improve their dosage and obtain new routes of administration or indications.
  • Development of generic specialties for licensing to third parties, maintaining manufacturing in the company’s production facilities.

With regard to dosage forms, Reig Jofre combines the strengths of its R&D team with a high-end production capacity in three areas of high added-value:

  • Penicillin antibiotics in all dosage forms: injections (sterile powder vials), tablets, capsules, sachets and syrups.
  • Cephalosporin antibiotics: sterile powder for injection in vials.
  • Lyophilised vials for all types of APIs:
    • Thermal analysis in lyophilization.
    • Application of DSC (differential scanning calorimetry), FDM (lyophilization microscope) and DTA-ER (differential thermal analysis and electrical resistance) techniques.
    • Development and optimization of lyophilization recipes in pilot plant.
    • Industrial scale process.
    • Applications in generics, proteins, monoclonal antibodies, vaccines, etc.

The company also has extensive development and production strength in:

  • Liquid dosage forms: oral and topical solutions in ampoules and sterile vials, syrups, liquids in single-dose sachets and swabs.
  • Semi-solid forms: ointments, emulsions, micro-emulsions, and creams.
  • Solid oral dosage forms: capsules, tablets, coated tablets and lozenges.

Finally, Reig Jofre’s R&D team has extensive experience in coordinating and conducting preclinical and clinical (Phase I-IV) ADMET studies required for the development both of proprietary products and of third-party products.

To this end, Reig Jofre has a mass spectrometry (LC_MS/MS) service that is mainly specialized in bioanalysis and covered by a "Good Laboratory Practice" (GLP) certification.

This site uses only technical third party cookies to provide better service, when browsing this website you agree to its use. See ourlegal advice. Agree

DMC Firewall is developed by Dean Marshall Consultancy Ltd